ClinicalTrials.gov
public full text
Public Domain
Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptoms in comparison to oxycodone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacologic Management of Pain in Children: Balancing Evidence, Safety, and Clinical Challenges.#1091411
- Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain#1103225
- Clonidine-induced Spinal Acetylcholine Release: Normal Volunteers vs. Neuropathic Pain#853833
- Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery#889840
- Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial#967104
Record · ID 872179
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive